In the first week of February, stocks tumbled 10% (defined as a correction) from their all-time high on Jan. 26. Before that, the S&P 500 had climbed mostly without interruption since the last correction in mid-2015.
Sudden corrections certainly seem scary as they’re happening. But in reality, they present investors a rare opportunity to purchase quality stocks at a discount.
A month ago, Teslas closing stock price peaked at $383.45, and last week the stock closed below $330.
Tesla Inc. Powerpacks and inverters stand at the Southern California Edison Co. Mira Loma energy storage system facility in Ontario, California, U.S., on Thursday, June 1, 2017. The Mira Loma substation houses nearly 400 Tesla Powerpack units, in an effort to operate to state regulations....More>>>
For full access, Log in or Subscribe Now and get 4 weeks free! ....More>>>
Spark Therapeutics (NASDAQ:ONCE) was the target of some unusual options trading activity on Thursday. Investors acquired 551 put options on the company. This represents an increase of 884% compared to the average volume of 56 put options.
A number of equities research analysts have recently weighed in on the stock. ValuEngine upgraded shares of Spark Therapeutics from a “hold”....More>>>
Investment company Carl Icahn buys Welbilt Inc, sells Federal-Mogul Holdings Corp, Nuance Communications Inc, Allergan PLC during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, Icahn Capital Management LP. As of 2017-03-31, Icahn Capital Management LP owns 16 stocks with a total value of $19.9 billion. These are the details of the buys and sells.
Shares of Spark Therapeutics (NASDAQ:ONCE) have seen a nice bounce recently, having risen by 30% since late February. It looks like my “buy the dip” piece in late November was followed by a much larger “dip” than I was expecting (Note: This was an unexpected event and great example of how biotech is a minefield).
Figure 1: ONCE daily advanced chart (Source:....More>>>
After positive mid-stage trial data suggested earlier this year that it might be able to reshape the treatment of kidney failure in lupus patients, Aurinia Pharmaceuticals (NASDAQ:AUPH)has announced plans for a late-stage study that could eventually allow it to win regulatory OKs in the U.S., Europe, and Japan.
What’s going on
Aurinia Pharmaceuticals is working on voclosporin,....More>>>
The euro gained against the dollar on Tuesday, with analysts attributing the rally to centrist candidate Emmanuel Macron performing well in Frances first televised presidential debate.
The shared currency
Jackson, MI, based Investment company Dillon & Associates Inc buys JPMorgan Chase, Danaher, Analog Devices, Honeywell International, Merck, Wells Fargo, AT&T, Paycom Software, The Kraft Heinz Co, sells Linear Technology, The Hain Celestial Group, Versum Materials, Bioverativ during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, Dillon &....More>>>
Is Facebook Inc stock a good buy near its all-time high price?
Shares of Menlo Park, California-basedFacebook Inc.(NASDAQ:FB)are on a roll in 2017, gaining more than 21% YTD after a lackluster 2016. FB stock is trading near its all-time high of $139.68. FB stock has been driven by multiple factors. At large, the strong bullish rally has been on account of strong revenue growth....More>>>